Preservative-Free Ganfort Formulation Gains Marketing Authorization For Glaucoma In EU

Home
Cataract
Cornea
Glaucoma
Refractive
Retina
Practice Management

Friday, September 6, 2013

Comments

Ocular Surgery News

A preservative-free, single-dose formulation of Ganfort ophthalmic solution has been granted marketing authorization covering all 27 European Union countries by the European Medicines Agency, according to a news release.

Full Story

Aspirin usage increases the risk of bleeding in patients with proliferative retinopathy?
1. True
2. False
Check The Answer

CIRRUS™ HD-OCT 5000 with FastTrac™ - The Clinical Powerhouse
CIRRUS HD-OCT 5000 is configured with ... view product
Volk iNview
iPhone Fundus Camera The Volk iNview ... view product

View all Featured Products »

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

Learn more about writing for us

AdGlare Leaderboard

Preservative-Free Ganfort Formulation Gains Marketing Authorization For Glaucoma In EU

Comments

Quick Quiz

Aspirin usage increases the risk of bleeding in patients with proliferative retinopathy?

AdGlare RMR Ad

Featured Products

CIRRUS™ HD-OCT 5000 with FastTrac™ - The Clinical Powerhouse

Volk iNview

Follow OphthalmologyWeb

AdGlare RMR2

Write for Us